A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Clinical trial NCT07308548 · RECRUITING

Trial details

NCT number: NCT07308548
Sponsor: Hinova Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NAFLD (Non-alcoholic Fatty Liver Disease)

Start date: 2025-10-11
Primary completion: 2026-08-13
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.